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Abstract  
Introduction. Chronic kidney disease patients on dialysis report a worse quality of life as compared to 
the general population due to limitations in daily functioning. Worrying and self-efficacy may 
influence a patient’s quality of life. The aim of the study was to clarify the association between 
worrying, self-efficacy and quality of life in renal patients on dialysis. 
Method. 126 patients at baseline and 65 patients at half year follow-up completed questionnaire 
booklets about emotional functioning, social functioning, physical functioning, worrying and self-
efficacy.  
Results. No differences in quality of life at baseline and after six months were found. Patients with 
higher levels of worrying experienced higher levels of fatigue, depression and anxiety, and lower 
levels of emotional wellbeing and perceived support. Patients with higher levels of self-efficacy 
experienced higher levels of emotional wellbeing and perceived support, and lower levels of 
symptoms/problems, fatigue, depression and anxiety. Worrying predicted a decrease in emotional 
functioning over a period of six months. 
Discussion. Treatments focused on worrying and self-efficacy can lead to an increase in the quality of 
life. Future research can be focused on other changeable predictors for the quality of life. 
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Introduction  
In the Netherlands, the prevalence of chronic kidney disease (CKD) in adults is 6.7 percent with an 
incidence rate of 1,213 per 100,000 person-years (van Blijderveen et al., 2014). CKD refers to 
difficulties in kidney function or kidney damage for at least three months (Eknoyan, & Levin, 2002; 
Levey et al., 2003). By determining the glomerular filtration rate (GFR) the severity of the disease can 
be measured, indicated by different stages, in which a lower GFR indicates less functioning of the 
kidneys. The last stage of CKD is end stage renal disease (ESRD), in which the GFR is the lowest. 
After receiving the diagnosis of ESRD, the best option for treatment is renal transplantation, because 
ESRD is not curable without transplantation (Levey et al., 2003). Because often this is not a possible 
option due to the lack of organ donors, patients can be treated with hemodialysis or peritoneal dialysis. 
Hemodialysis means that the blood is purified in a dialyzer outside the body where a partially 
permeable membrane is located (Ahmad, Misra, Hoenich, & Daugirdas, 2008). That membrane 
separates the blood from water and wastes, whereafter the purified blood is pumped back into the 
body. Usually, this process is repeated three to five times a week and takes about four hours each time. 
This treatment mostly takes place in hospital or in a dialysis center, and sometimes at home (Ahmad et 
al., 2008). Peritoneal dialysis is when a glucose solution is inserted into the abdominal cavity through 
a catheter (Blake & Daugirdas, 2008). The fluid takes up wastes and redundant fluid and have to be 
replaced when it is saturated. This should be done four or five times a day and usually takes place at 
home. Although dialysis leads to a decrease in physical fluid levels and toxins, it also leads to 
adjustment problems in many cases (Mohr et al., 2001). These problems can consist of a modified 
daily schedule, need for extra help, sleep disturbances, emotional problems, isolation and symptoms 
like itch, fluid accumulation and nausea. These negative consequences of the dialysis can cause a 
decreased quality of life.  
 
Quality of life 
Quality of life refers to people’s own experience of their functioning in terms of physical, 
psychological and social wellbeing (Cella, 1994). Research has found that CKD patients on dialysis 
report a worse quality of life as compared to the general population due to limitations in daily 
functioning (Evans et al., 1985; Merkus et al., 1997; Mittal et al., 2001). In patients who underwent 
pre-dialysis treatment, it was found that all symptoms increased and the physical and mental health 
decreased over time already (de Goeij et al., 2014). Prospective studies regarding the changeability of 
quality of life in renal patients on dialysis found inconsistent results. During a period of two years 
follow-up, it was found that the quality of life deteriorated slowly in terms of general health, 
symptoms/problems, burden of kidney disease, emotional wellbeing, and patient satisfaction, which 
may be (partly) due to increased hospital admissions (Bakewell, Higgins, & Edmunds, 2002).  
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However, Mazairac et al. (2010) found an improvement in the quality of life in hemodialysis patients 
over an 11-year period of time, in terms of bodily pain, vitality, role-emotional and mental health, 
which may be partly due to improved haemoglobin and phosphate levels. Two other studies also found 
an improvement in quality of life in patients with hemodialysis or peritoneal dialysis during a period 
of one and two years of follow-up (Santos, Daher, Silva Jr, Libório, & Kerr, 2009; Wu et al., 2004). 
Some studies found changes in different quality of life factors. Merkus et al. (1999) found a decrease 
in physical quality of life and no change in mental quality of life over a period of 18 months and a 
study of Gabbay, Meyer, Griffith, Richardson and Miskulin (2010) found no difference in quality of 
life in hemodialysis patients, only an improvement in role-emotional health. Other studies found no 
differences in quality of life in renal patients over time (Manns et al., 2003; Mittal et al., 2001). 
Because of the different results, more research is required to draw a clear conclusion about the 
changeability of the quality of life in renal patients on dialysis. If more knowledge about the 
changeability is available, specific treatments for specific areas of the quality of life can be 
implemented (preventively) to improve the quality of life as well as possible. 
 
Worrying & self-efficacy 
According to the bio-psycho-social model (Engel, 1977), the combination of biological factors (in this 
case ESRD), psychological factors (for example depression, anxiety and worrying, or a lack of self-
efficacy) and social factors (for example, decreased social life) can cause a decreased quality of life. 
One of the psychological factors that may influence a patient’s quality of life is worrying. 
Worrying is defined as an unwanted, uncontrollable, aversive cognitive activity associated with 
negative thoughts and some sense of emotional discomfort (Borkovec, 1994; Borkovec & Lyonfields, 
1992). In the general population, it was found that worrying is negatively associated with quality of 
life, and positively associated with depression and symptom reporting (Golden et al., 2011; Rief et al., 
2012). In renal patients, worrying can be caused by, for example, a lack of knowledge about the 
disease, treatments and coping, fear of complications, progression or death, less perceived personal 
control and avoidance (Davey, Hampton, Farrell, & Davidson, 1992; Finkelstein et al., 2008). Little 
information is available with regard to worrying in renal patients. Available studies found an 
association between worrying and quality of life (especially social functioning and mental health) in 
renal patients on dialysis (Kao et al., 2009) and found that a decrease in worrying led to an 
improvement of the quality of life (Augusto, Krzesinski, Warling, Smelten, & Etienne, 2011). Studies 
in other chronic diseases found also a negative association between worrying and quality of life in 
patients with cancer (Deimling, Bowman, Sterns, Wagner, & Kahana, 2006), breast cancer (Waters, 
Liu, Schootman, & Jeffe, 2013), epilepsy (Barahmand & Haji, 2014) and hepatitis C (Häuser, Zimmer, 
Schiedermaier, & Grandt, 2004). All studies showed a consistently negative association between 
worrying and quality of life, but more research in renal patients is needed to clarify its predictive role 
for quality of life.   
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 Another factor that can influence the quality of life of patients is self-efficacy. Self-efficacy 
refers to the belief in one’s ability to successfully influence events in his or her environment (Bandura, 
1997). According to Bandura’s self-efficacy theory people are more able to manage their disease when 
they are educated about it and feel strong to cope with it in a positive way (Bandura, 1997). People 
with high self-efficacy stay to their goals and recover more quickly after negative events. In addition, 
self-efficacy would lead to adherence, health behavior, effective pain management, disease 
management, more positive emotions and the expansion of satisfying social relations. These factors 
may contribute to an improved quality of life (Bandura, 1997; Cramm et al., 2013). Most studies found 
a positive relationship between self-efficacy and quality of life in renal patients on dialysis (Cramm, 
Strating, Roebroeck, & Nieboer, 2013; Han, Lee, Lee, & Park, 2003; Lev & Owen, 1998; Perales-
Montilla, García-León, & Reyes-del Paso, 2012; Tsay & Healstead, 2002), except for the study of 
Curtin et al. (2008), which found a correlation between self-efficacy and increased communication, 
partnership, self-care and medication-adherence behaviors, but no correlation with physical and mental 
health. Two studies found that self-efficacy was a significant predictor of a better quality of life in 
renal patients on dialysis (Cramm et al., 2013; Tsay & Healstead, 2002), but more research about the 
predictive role of self-efficacy for quality of life is required. 
 
Although the quality of life in association with the psychological factors worrying and self-efficacy 
have to a limited extent been previously studied in renal patients on dialysis, research about ESRD and 
potential predictors for (changes in) the quality of life can be extended. These factors are relevant for 
study because of the importance of improving the quality of life in renal patients. If more knowledge 
about the quality of life and its potential predictors in renal patients on dialysis is available, doctors 
and psychologists can develop and evaluate treatments aimed at improving quality of life, for example 
by means of these targeting predictors, enabling patients to live a better life. 
 This study will focus on three research questions. The first question concerns the stability 
versus change in quality of life (in terms of social functioning, emotional functioning and physical 
functioning) in renal patients over a period of six months during long-term dialysis treatment. The 
second question is focused on the association of worrying and self-efficacy with quality of life in renal 
patients on dialysis. The last research question concerns the prediction of worrying and self-efficacy 
for a change in quality of life in renal patients over a period of six months during long-term dialysis 
treatment. The literature with regard to the changeability of the quality of life was inconclusive. Six 
months is a relatively short period of time for detecting changes over time. In addition, several studies 
with a longer period of follow-up observed no changes over time. Therefore, it is expected that there 
will be no change in quality of life in renal patients over a period of six months during long-term 
dialysis treatment.  
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Corresponding with the literature, worrying will be negatively and self-efficacy will be positively 
associated with quality of life in renal patients on dialysis, and lastly, worrying will be a predictor of a 
deterioration and self-efficacy of an improvement in quality of life in renal patients over a period of 
six months during long-term dialysis treatment. 
 
Method 
Design 
The study was a prospective population study focused on adjustment problems and risk/resilience 
factors in renal patients on dialysis. This thesis is focused on worrying and self-efficacy related to 
social functioning, emotional functioning and physical functioning in renal patients on dialysis. These 
factors were measured two times by means of two questionnaire booklets six months apart. 
 
Participants 
The research population consisted of patients with end stage renal disease. Participants were acquired 
from the dialysis department of the Radboud university medical center in Nijmegen, Canisius-
Wilhelmina hospital in Nijmegen, VieCuri (Medical Center for Noord-Limburg), Bernhoven in Uden 
and dialysis center Ravenstein, in the Netherlands. The inclusion criteria were that the patients were 
older than eighteen years and received either hemodialysis or peritoneal dialysis. Patients were 
excluded from this study when they did not speak Dutch, had severe comorbid physical problems with 
a life expectancy of less than six months, had severe comorbid psychiatric problems or when they had 
experienced a major life event in the recent past. Medical files were screened to select patients for 
participation. 
 
Procedure 
Participants were approached by the research nurse or nephrologist of the dialysis department of the 
Radboud university medical center. When the patients were interested in the study, they received oral 
information about the background and goals of the study, the questionnaire and advantages and 
disadvantages of participating. After patients had decided to participate in the study, the participants 
received an envelope with further information, an informed consent form and the coded questionnaire. 
The participants could read the information at home, fill in the questionnaire and send back the signed 
informed consent form and filled out questionnaire booklet to the coordinating research nurse in the 
Radboud university medical center. Completing both questionnaires took about one hour each. The 
participants could stop filling in the questionnaire at every moment. The study did not need approval 
of the Medical Research Ethics Committee of the CMO region Arnhem-Nijmegen.   
 
 
 
 8 
Instruments   
The patients received two questionnaire booklets, one at baseline and one at six months follow up. The 
questionnaires that are used to test the hypotheses were part of a larger set of questionnaires. The 
questionnaires of the constructs that were measured for the current study will be described below.  
  
 Sociodemographic and clinical characteristics. The first part of the first questionnaire 
consisted of questions about the personal situation. These questions were about sex, age, education, 
marital status, children, ethnicity, religion, work status, dialysis (frequency and last time), comorbid 
conditions, negative life event(s), influence on the choice of the treatment, and about kidney 
transplantation. The questions were open or answered on Likert scales with space for comments.  
Quality of life.  
 Emotional functioning. Emotional functioning was assessed by means of the emotional 
wellbeing scale of the Kidney Disease Quality of Life Short Form, the KDQOL-SF (Korevaar et al., 
2002) and the Hospital Anxiety and Depression Scale, the HADS (Zigmond & Snaith, 1983).  
 The KDQOL-SF measures the quality of life in renal patients on dialysis, and consists of 80 
items about symptom/problems, effects of kidney disease on daily life, burden of kidney disease, work 
status, cognitive functioning, quality of social interaction, sexual functioning, sleep, social support, 
dialysis staff encouragement, patient satisfaction, physical functioning, role limitations caused by 
physical health problems, role limitations caused by emotional health problems, social functioning, 
emotional wellbeing, pain, energy/fatigue, general health perceptions and overall health. The 
emotional wellbeing scale consists of five items with a six-point Likert scale ranging from ‘all of the 
time’ to ‘none of the time’ with questions like “Have you been a very nervous person?” and “Have 
you been a happy person?”, in the last four weeks. The items are recoded into items ranging from 0 to 
100, in which high scores mean high emotional functioning. The validity of de KDQOL-SF in renal 
patients is good (Korevaar et al., 2002). The internal consistency of the emotional wellbeing scale in 
our sample was .829.  
 The HADS is mostly used in hospital setting and measures anxiety and depression in patients. 
The questionnaire consists of fourteen questions with seven questions about anxiety. For example: “I 
get a sort of frightened feeling as if something awful is about to happen”) and seven questions about 
depression. For example: “I look forward with enjoyment to things”. Answers are given by means of a 
four-point Likert scale. Patients could have a score from zero to three on each question, so their scores 
varied from zero to twenty-one for anxiety and depression, in which a high scores mean more anxiety 
and depression. It was found that the HADS is a valid screening instrument in renal patients 
(Loosman, Siegert, Korzec, & Honig, 2010). In our sample, the internal consistency of the HADS was 
.883. 
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 Social functioning. Social functioning was measured through the social functioning scale of 
the KDQOL-SF (Korevaar et al., 2002) and the perceived support scale of the social dimension of the 
Impact of Rheumatic diseases on General Health and Lifestyle, the IRGL (Huiskes, Kraaimaat, & 
Bijlsma, 1990).  
 The social functioning scale of the KDQOL-SF consists of two items on a four-point Likert 
scale ranging from ‘very dissatisfied’ to ‘very satisfied’ with the questions “How satisfied are you 
with the amount of time you are able to spend with your family and friends?” and “How satisfied are 
you with the support you receive from your family and friends?”. The items are recoded into items 
ranging from 0 to 100, in which high scores mean high social functioning. In our sample, the internal 
consistency of the social functioning scale was .828.  
 The IRGL measures the health status in rheumatic patients. The perceived support scale of the 
social dimension of the IRGL consists of five items with a four-point Likert scale ranging from 
‘almost never’ to ‘almost always’ including questions like “When I am sad, there is someone to share 
it with me” and “When I am tense or under pressure, there is somebody to help me”. With regard to 
this scale, a higher score means higher perceived support. The validity of the questionnaire in 
rheumatic patients is good (Huiskes et al., 1990). The internal consistency of the perceived support 
scale in our sample was .870.  
 Physical functioning. Physical functioning was assessed by means of the physical functioning 
scale and the symptom/problems scale of the KDQOL-SF (Korevaar et al., 2002), and the subjective 
fatigue scale of the Checklist Individual Strength, the CIS (Vercoulen, Alberts, & Bleijenberg, 1999). 
 The physical functioning scale of the KDQOL-SF consists of ten items on a three-point Likert 
scale ranging from ‘yes, limited a lot’ to ‘no, not limited at all’ with statements like “Climbing several 
flights of stairs” and “Bathing or dressing yourself”. The items are recoded into items ranging from 0 
to 100, in which high scores mean high physical functioning. The internal consistency of this scale in 
our sample was .957. The symptom/problems scale of the KDQOL-SF consists of twelve items on a 
five-point Likert scale ranging from ‘not at all bothered’ to ‘extremely bothered’. Examples of 
questions in this scale are: “Chest pain” and “Washed out or drained”. The items are recoded into 
items ranging from 0 to 100, in which a high score means more wellbeing or less symptoms. The 
internal consistency of the symptoms/problems scale in our sample was .853.  
 The CIS measures fatigue and behaviors related to fatigue by using four dimensions: 
subjective fatigue, concentration, motivation and physical activity (Vercoulen et al., 1999). The 
subjective fatigue scale consists of eight statements about fatigue in the last two weeks with a seven-
point scale ranging from ‘yes, that is correct’ to ‘no, that is not correct’, for example “I feel tired” and 
“Physically I feel I am in bad form”, in which a high score means more fatigue. The validity of the 
CIS is good in the working population and CVS patients (Beurskens et al., 2000; Vercoulen et al., 
1994) and the internal consistency of the subjective fatigue in our sample was .921.  
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 Psychological factors.  
 Worrying. Worrying was measured by means of the Penn State Worry Questionnaire, the 
PSWQ (Meyer, Miller, Metzger, & Borkovec, 1990). The PSWQ consists of sixteen items about the 
tendency, severity and uncontrollability of worrying that can be scored on a five-point scale ranging 
from ‘not at all typical of me’ to ‘very typical of me’ with questions like “If I do not have enough time 
to do everything, I do not worry about it” and “I have been a worrier all my life”, in which a high 
score means more worrying.  
The validity of this questionnaire is good in the general population (Meyer et al., 1990). The internal 
consistency of the PSWQ in our sample was .716. 
 Self-efficacy. Self-efficacy was assessed by means of the Generalized Self-Efficacy Scale, the 
GSES (Sherer & Maddux, 1982). The GSES measures self-efficacy, the confidence in patients own 
ability to cope with new or difficult situations or obstacles. The questionnaire consists of ten items and 
the answers are scaled on a four-point Likert scale ranging from ‘completely false’ to ‘completely 
true’, with statements like “I can always manage to solve difficult problems if I try hard enough” and 
“Thanks to my resourcefulness, I know how to handle unforeseen situations”. A higher score means 
higher self-efficacy. The validity of the GSES is good in the general population (Sherer & Maddux, 
1982) and the internal consistency in our sample was .816.   
 
Data analysis  
First, all variables of the questionnaires described above were checked on possible values on item 
level, internal consistency, kurtosis, skewness and outliers. Outliers on all variables assessed were 
defined as scores that differed more than three standard deviations from the mean score in the sample. 
Analyses with and without outliers were compared. Also the patients characteristics were explored and 
described in terms of mean and standard deviation or number and percentage. Before running the 
analyses the necessary assumptions were checked. Because data about the quality of life are missing at 
follow-up, the mean of the baseline data of the quality of life measures between the participants who 
filled in only the first questionnaire booklet and the participants who filled in both booklets were 
compared with independent samples t-tests. 
 To examine the stability of the quality of life across six months of dialysis, the scores of social 
functioning, emotional functioning and physical symptoms at the first and second assessment were 
compared by means of paired sample t-tests for each variable separately. To examine the association 
between worrying and self-effiacy and the quality of life at baseline, Pearson correlational analyses 
were performed. To examine the predictive value of worrying and self-efficacy on a change in quality 
of life over a period of six months dialysis treatment, multiple regression analyses were performed. 
Worrying and self-efficacy of the first assessment were the independent variables and social 
functioning, emotional functioning and physical functioning of the measure after six months were the 
dependent variables.  
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These variables were performed in separate analyses for each measure of quality of life. In these 
analyses, we controlled for the first assessment of social functioning, emotional functioning and 
physical functioning separately to assess the improvement or deterioration of the quality of life. If 
necessary, the dependent and independent variables were corrected by covariates like age, sex and 
education level, because of the impact that these factors can have on quality of life. The influence of 
the covariates on the clinical variables was explored through correlation analyses and the covariates 
were added when the correlations with the clinical variables were significant with several variables. 
The analyses described were performed by using IBM SPSS statistics for Windows, version 21.0. In 
all analyses, scores were mentioned as significant if p < .05. 
 
Results 
Participants 
The data consisted of 126 participants for the first assessment and 65 for the second assessment. No 
participants were excluded because of not meeting the inclusion criteria. Outliers were explored 
through boxplots and the analyses with outliers were compared with the analyses without outliers. 
Because no significant differences were found, the outliers were retained. The descriptive statistics of 
the demographic information of the participants are described in table 1. The majority of the 
participants consisted of men with an age ranging from 28 to 91 years. Most participants had a 
secondary education level, hemodialysis during the day and several comorbidities.  
 Because data about the quality of life of 61 participants are missing at follow-up, the mean of 
the baseline data of the quality of life measures between the participants who filled in only the first 
questionnaire booklet and the participants who filled in both booklets were compared with 
independent samples t-tests. No significant results were found (symptoms/problems: p = .925; fatigue: 
p = .729; emotional wellbeing: p = .662; depression: p = .176; anxiety: p = .683; social functioning: p 
= .171; and perceived support: p = .239), but a trend was found in physical functioning in both groups 
(p = .051). That means that both groups of participants scored not significantly different on quality of 
life at baseline, making that the participants at follow-up are generalizable for the total group of 
participants. 
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Table 1 
Patient characteristics 
Age – M (SD) 69.03 (15.11) 
Sex – N (%) 
     Women  
     Men  
     Unknown  
 
48 (38.10) 
77 (61.10) 
1 (.80) 
Education – N (%) 
     Primary   
     Secondary  
     Tertiary 
     Unknown  
 
27 (21.40) 
73 (57.90) 
18 (14.30) 
8 (6.30) 
Religion – N (%) 
     Yes 
     No  
     Unknown  
 
85 (67.50)  
36 (28.60) 
5 (4.00) 
Type of dialysis – N (%) 
     Hemodialysis day 
     Hemodialysis night 
     Peritoneal dialysis 
     Hemodialysis at home 
 
99 (78.60) 
3 (2.40) 
9 (7.10) 
15 (11.90) 
Comorbidity – N (%) 
     Yes  
     No  
     Unknown 
 
95 (75.40) 
25 (19.80) 
6 (4.80) 
Comorbidity: yes – N (%) 
     High blood pressure 
     Heart disease 
     Diabetes  
     Cancer  
     Lung disease 
     Liver disease 
     Gastrointestinal disease 
     Blood disease 
     ME 
     Rheumatic disease 
     Other physical disease 
Psychological symptoms (eating problems,      
alcohol problems, drugs abuse, depressive     
symptoms, anxiety symptoms, psychotic 
episodes or different) 
 
56 (44.40) 
34 (27.00) 
22 (17.5) 
6 (4.80) 
14 (11.10) 
1 (.80) 
5 (4.00) 
1 (.80) 
7 (5.60) 
7 (5.60) 
29 (23.00) 
11 (8.70) 
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Children – N (%) 
     Yes 
     No  
     Unknown  
 
97 (77.00) 
26 (20.60) 
3 (2.40) 
Waiting list transplantation – N (%) 
     Yes  
     No 
     Unknown  
 
22 (17.50) 
102 (81.00) 
2 (1.60) 
Ever transplanted – N (%) 
     Yes 
     No 
 
24 (19.00) 
102 (81.00) 
Note. M=mean. SD=standard deviation. N=number of participants.  
 
Quality of life  
In table 2, the descriptive statistics of the variables that measure quality of life at baseline and follow-
up and the predictors worrying and self-efficacy are described, as well as the outcomes of the paired 
samples t-tests comparing baseline and follow-up scores. In the paired samples t-tests to test whether 
quality of life changed over time, no significant differences were found with regard to physical 
functioning, emotional functioning and social functioning at baseline and after six months during 
dialysis treatment. The first hypothesis is adopted. 
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Table 2 
Descriptive statistics QoL-variables and predictors with analysis 
Variables  Assessment 
1 
 Assessment 
2 
 Analysis   
 M SD M SD t df p 
Physical 
functioning 
       
Physical functioning  46.36 29.42 48.63 29.39 .974 61 .334 
Symptoms/problems  77.41 14.91 77.63 14.19 -.146 61 .884 
Fatigue  34.80 13.13 34.65 11.80 -.141 60 .889 
Emotional 
functioning 
       
Emotional 
wellbeing 
76.03 16.51 75.63 16.00 .010 59 .992 
Depression 5.72 3.82 5.53 3.89 -1.174 60 .245 
Anxiety  4.17 3.78 4.17 3.21 -1.100 60 .276 
Social functioning        
Social functioning 67.90 26.63 69.23 24.61 .701 63 .486 
Perceived support 15.98 3.61 16.08 3.66 .858 64 .394 
Predictors         
Worrying  38.72 10.46      
Self-efficacy  30.35 4.86      
Note. M=mean. SD=standard deviation. N=number of participants. 
Worrying & self-efficacy 
Table 3 shows the results of the correlational analyses between worrying and self-efficacy and 
physical functioning, emotional functioning and social functioning at baseline. In the correlational and 
regression analyses, the covariates sex (man/woman), age, education (primary/secondary/tertiary) and 
children (yes/no) were added because of the significant association with several quality of life 
measures. Being a woman was associated with higher levels of anxiety and being a man was 
associated with higher levels of social functioning, higher age was associated with lower levels of 
physical functioning, a higher education level was associated with higher levels of physical 
functioning, and having children was associated with higher levels of depression.  
 The correlations between worrying and fatigue, emotional wellbeing, depression, anxiety and 
perceived support were found significant, in which higher levels of fatigue, depression and anxiety 
were associated with higher levels of worry, whereas lower levels of emotional wellbeing and 
perceived support were associated with higher levels of worrying.  
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Also the correlations between self-efficacy and symptoms/problems, fatigue, emotional wellbeing, 
depression, anxiety and perceived support were found significant, in which higher levels of 
symptoms/problems, emotional wellbeing and perceived support were associated with higher levels of 
self-efficacy, whereas lower levels of fatigue, depression and anxiety were associated with higher 
levels of self-efficacy. With regard to the covariates, higher age was associated with lower levels of 
worrying. A negative trend was found with regard to worrying and symptoms/problems. This means 
that higher levels of worrying were (not significantly) associated with more symptoms. Physical and 
social functioning were not associated with both worrying or self-efficacy. With regard to the quality 
of life domains physical functioning, emotional functioning and social functioning in total, physical 
functioning and social functioning were partially associated with worrying and self-efficacy and 
emotional functioning was associated with worrying and self-efficacy as a whole. The second 
hypothesis was adopted with regard to the relationship between worrying and fatigue, emotional 
wellbeing, depression, anxiety and perceived support, and self-efficacy and symptoms/problems, 
fatigue, emotional wellbeing, depression, anxiety and perceived support. The hypothesis was rejected 
with regard to the relationship between worrying and physical functioning, symptoms/problems and 
social functioning and self-efficacy and physical functioning and social functioning.   
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Table 3 
Correlations predictors and quality of life factors 
Variables  Worrying  Self-efficacy  
 r p r p 
Physical functioning     
Physical functioning  -.002 .984 .102 .274 
Symptoms/problems  -.170 .065 .269* .004 
Fatigue  .335* .000 -.258* .005 
Emotional functioning     
Emotional wellbeing -.590* .000 .491* .000 
Depression .472* .000 -.341* .000 
Anxiety  .673* .000 -.324* .000 
Social functioning     
Social functioning -.144 .118 .155 .096 
Perceived support -.256* .005 .312* .001 
Covariates      
Sex -.152 .097 .130 .162 
Age  -.189* .044 .000 1.000 
Education .026 .782 .069 .474 
Children  -.103 .269 -.118 .208 
Note. r=Pearson correlation. * p < .05 
 
Prediction of quality of life 
Table 4 to 10 shows the multiple regression analyses of worrying and self-efficacy and the quality of 
life factors at baseline and after six months, including covariates. Table 4 shows the prediction of 
physical functioning during six months dialysis treatment. In model 1 the influence of physical 
functioning at baseline and the covariates on physical functioning after six months were examined. 
Model 1 was significant, F (5, 47) = 18.713, p < .001 and R² = .666. In model 2 also worrying and 
self-efficacy were examined. Model 2 was significant, F (7, 45) = 13.027, p < .001. However, only 
physical functioning at baseline and sex were found significant with physical functioning after six 
months. That means that physical functioning at baseline and being a man predict physical functioning 
after six months of dialysis treatment. No significant results were found with regard to worrying and 
self-efficacy. That means that worrying and self-efficacy at baseline do not predict changes in physical 
functioning over a period of six months during dialysis treatment, ΔR² = .004. 
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Table 4 
Predictors of physical functioning after six months dialysis treatment 
Model 
  
t p B SEa βb 
1 Physical functioning 
baseline 
 
.578 
 
.098 
 
.591 
 
5.900 
 
.000* 
Sex  14.334 5.036 .251 2.846 .007* 
Age -.103 .212 -.053 -.484 .631 
Education  4.589 4.245 .099 1.081 .285 
Children  -10.191 6.610 -.155 -1.542 .130 
2 Physical functioning 
baseline 
.559 .104 .572 5.398 .000* 
Sex  13.459 5.255 .236 2.561 .014* 
Age  -.122 .218 -.062 -.559 .579 
Education  5.429 4.463 .118 1.217 .230 
Children  -9.421 6.801 -.143 -1.385 .173 
Worrying  -.097 .272 -.032 -.356 .724 
Self-efficacy .373 .636 .056 .587 .560 
Notitie. * p < .05
 
a 
SE = standard error
 
b 
β = standardized beta 
 
Table 5 shows the prediction of symptoms during six months dialysis treatment. In model 1 the 
influence of symptoms at baseline and the covariates on symptoms after six months were examined. 
Model 1 was significant, F (5, 47) = 14.629, p < .001 and R² = .609. In model 2 also worrying and 
self-efficacy were examined. Model 2 was significant, F (7, 45) = 10.952, p < .001. However, only 
symptoms at baseline were found significant with symptoms after six months. That means that 
symptoms at baseline predict symptoms after six months of dialysis treatment. No significant results 
were found with regard to worrying and self-efficacy. That means that worrying and self-efficacy at 
baseline do not predict changes in symptoms over a period of six months during dialysis treatment, 
ΔR² = .021. 
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Table 5 
Predictors of symptoms after six months dialysis treatment 
Model 
  
t p B SEa βb 
1 Symptoms baseline .740 .096 .750 7.734 .000* 
Sex  3.686 2.701 .129 1.365 .179 
Age .095 .112 .096 .849 .400 
Education  3.108 2.277 .135 1.365 .179 
Children  -.730 3.736 -.022 -.195 .846 
2 Symptoms baseline .737 .102 .747 7.203 .000* 
Sex  3.880 2.743 .135 1.414 .164 
Age  .077 .111 .078 .692 .492 
Education  3.160 2.331 .137 1.356 .182 
Children  -1.046 3.720 -.032 -.281 .780 
Worrying  -.196 .148 -.127 -1.321 .193 
Self-efficacy -.338 .343 -.099 -.986 .329 
Notitie. * p < .05
 
a 
SE = standard error
 
b 
β = standardized beta 
 
Table 6 shows the prediction of fatigue during six months dialysis treatment. In model 1 the influence 
of fatigue at baseline and the covariates on fatigue after six months were examined. Model 1 was 
significant, F (5, 47) = 14.241, p < .001 and R² = .602. In model 2 also worrying and self-efficacy 
were examined. Model 2 was significant, F (7, 45) = 11.368, p < .001. However, only fatigue at 
baseline and education were found significant with fatigue after six months. That means that fatigue at 
baseline and education predict fatigue after six months of dialysis treatment. No significant results 
were found with regard to worrying and self-efficacy. That means that worrying and self-efficacy at 
baseline do not predict changes in fatigue over a period of six months during dialysis treatment,  
ΔR² = .036. 
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Table 6 
Predictors of fatigue after six months dialysis treatment 
Model 
  
t p B SE
a
 βb 
1 Fatigue baseline  .654 .091 .710 7.149 .000* 
Sex  -1.425 2.069 -.066 -.689 .494 
Age -.131 .083 -.171 -1.582 .120 
Education  -3.942 1.784 -.219 -2.209 .032* 
Children  3.853 2.879 .150 1.338 .187 
2 Fatigue baseline .632 .100 .686 6.315 .000* 
Sex  -1.720 2.058 -.079 -.836 .408 
Age  -.113 .081 -.147 -1.391 .171 
Education  -3.970 1.767 -.221 -2.247 .030* 
Children  4.369 2.815 .170 1.552 .128 
Worrying  .199 .115 .172 1.725 .091 
Self-efficacy .331 .254 .131 1.304 .199 
Notitie. * p < .05
 
a 
SE = standard error
 
b 
β = standardized beta 
 
Table 7 shows the prediction of emotional wellbeing during six months dialysis treatment. In model 1 
the influence of emotional wellbeing at baseline and the covariates on emotional wellbeing after six 
months were examined. Model 1 was significant, F (5, 45) = 7.899, p < .001 and R² = .467. In model 2 
also worrying and self-efficacy were examined. Model 2 was significant, F (7, 43) = 9.336, p < .001. 
However, only emotional wellbeing at baseline was found significant with emotional wellbeing after 
six months, as well as education in model 2. That means that emotional wellbeing at baseline and 
education predict emotional wellbeing after six months of dialysis treatment. Worrying was a 
significant negative predictor of emotional functioning. That means that worrying at baseline predicts 
a decrease in emotional functioning over a period of six months during dialysis treatment, ΔR² = .136. 
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Table 7 
Predictors of emotional wellbeing after six months dialysis treatment 
Model 
  
t p B SE
a
 βb 
1 Emotional 
wellbeing baseline  
.721 .135 .598 5.318 .000* 
Sex  4.645 3.866 .136 1.202 .236 
Age -.090 .157 -.078 -.577 .567 
Education  5.501 3.291 .196 1.671 .102 
Children  -.248 5.311 -.006 -.047 .963 
2 Emotional 
wellbeing baseline 
.333 .159 .277 2.100 .042* 
Sex  3.250 3.488 .095 .932 .357 
Age  -.109 .139 -.094 -.787 .436 
Education  8.175 3.012 .291 2.714 .010* 
Children  -1.010 4.725 -.025 -.214 .832 
Worrying  -.835 .224 -.460 -3.732 .001* 
Self-efficacy .554 .437 .141 1.269 .211 
Notitie. * p < .05
 
a 
SE = standard error
 
b 
β = standardized beta 
 
 
Table 8 shows the prediction of depression during six months dialysis treatment. In model 1 the 
influence of depression at baseline and the covariates on depression after six months were examined. 
Model 1 was significant, F (5, 46) = 14.772, p < .001 and R² = .616. In model 2 also worrying and 
self-efficacy were examined. Model 2 was significant, F (7, 44) = 11.441, p < .001. However, only 
depression at baseline was found significant with depression after six months. That means that 
depression at baseline predicts depression after six months of dialysis treatment. No significant results 
were found with regard to worrying and self-efficacy. That means that worrying and self-efficacy at 
baseline do not predict changes in depression over a period of six months during dialysis treatment, 
ΔR² = .029. 
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Table 8 
Predictors of depression after six months dialysis treatment 
Model 
  
t p B SE
a
 βb 
1 Depression 
baseline  
.796 .107 .751 7.417 .000* 
Sex  .136 .734 .017 .185 .854 
Age -.008 .030 -.030 -.280 .781 
Education  -.467 .650 -.070 -.718 .476 
Children  .718 1.063 .080 .675 .503 
2 Depression 
baseline 
.682 .122 .644 5.609 .000* 
Sex  .528 .754 .067 .701 .487 
Age  -.005 .029 -.018 -.172 .864 
Education  -.708 .653 -.107 -1.084 .284 
Children  .847 1.055 .094 .802 .427 
Worrying  .066 .044 .156 1.493 .143 
Self-efficacy -.103 .091 -.113 -1.136 .262 
Notitie. * p < .05
 
a 
SE = standard error
 
b 
β = standardized beta 
 
Table 9 shows the prediction of anxiety during six months dialysis treatment. In model 1 the influence 
of anxiety at baseline and the covariates on anxiety after six months were examined. Model 1 was 
significant, F (5, 46) = 11.372, p < .001 and R² = .553. In model 2 also worrying and self-efficacy 
were examined. Model 2 was significant, F (7, 44) = 9.650, p < .001. However, only anxiety at 
baseline was found significant with anxiety after six months. That means that anxiety at baseline 
predicts anxiety after six months of dialysis treatment. A trend was found in the prediction of anxiety 
through self-efficacy. No significant results were found with regard to worrying and self-efficacy. That 
means that worrying and self-efficacy at baseline do not predict changes in anxiety over a period of six 
months during dialysis treatment, ΔR² = .053. 
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Table 9 
Predictors of anxiety after six months dialysis treatment 
Model 
  
t p B SE
a
 βb 
1 Anxiety baseline  .720 .101 .772 7.124 .000* 
Sex  .649 .709 .097 .915 .365 
Age -.038 .027 -.166 -1.409 .166 
Education  -.726 .604 -.130 -1.202 .236 
Children  .958 .896 .126 1.068 .291 
2 Anxiety baseline .507 .157 .544 3.224 .002* 
Sex  .776 .699 .116 1.111 .273 
Age  -.029 .027 -.128 -1.100 .277 
Education  -.879 .588 -.157 -1.495 .142 
Children  .751 .871 .099 .862 .394 
Worrying  .079 .056 .224 1.419 .163 
Self-efficacy -.158 .079 -.206 -1.995 .052 
Notitie. * p < .05
 
a 
SE = standard error
 
b 
β = standardized beta 
 
Table 10 shows the prediction of social functioning during six months dialysis treatment. In model 1 
the influence of social functioning at baseline and the covariates on social functioning after six months 
were examined. Model 1 was significant, F (5, 47) = 11.282, p < .001 and R² = .546. In model 2 also 
worrying and self-efficacy were examined. Model 2 was significant, F (7, 45) = 8.597, p < .001. 
However, only social functioning at baseline was found significant with social functioning after six 
months. That means that social functioning at baseline predicts social functioning after six months of 
dialysis treatment. No significant results were found with regard to worrying and self-efficacy. That 
means that worrying and self-efficacy at baseline do not predict changes in social functioning over a 
period of six months during dialysis treatment, ΔR² = .027 
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Table 10 
Predictors of social functioning after six months dialysis treatment 
Model 
  
t p B SE
a
 βb 
1 Social functioning 
baseline  
.734 .114 .677 6.447 .000* 
Sex  -1.550 5.262 -.031 -.295 .770 
Age -.035 .208 -.020 -.166 .869 
Education  5.797 4.350 .142 1.333 .189 
Children  -10.773 6.989 -.186 -1.541 .130 
2 Social functioning 
baseline 
.650 .123 .599 5.267 .000* 
Sex  -2.840 5.316 -.056 -.534 .596 
Age  -.035 .207 -.020 -.167 .868 
Education  7.301 4.415 .179 1.654 .105 
Children  -10.265 6.978 -.177 -1.471 .148 
Worrying  -.396 .291 -.147 -1.360 .181 
Self-efficacy .560 .630 .096 .889 .378 
Notitie. * p < .05
 
a 
SE = standard error
 
b 
β = standardized beta 
 
Table 11 shows the prediction of perceived support during six months dialysis treatment. In model 1 
the influence of perceived support at baseline and the covariates on perceived support after six months 
were examined. Model 1 was significant, F (5, 48) = 20.242, p < .001 and R² = .678. In model 2 also 
worrying and self-efficacy were examined. Model 2 was significant, F (7, 46) = 14.672, p < .001. 
However, only perceived support at baseline and education were found significant with perceived 
support after six months. That means that perceived support at baseline and education predict 
perceived support after six months of dialysis treatment. In model 2, sex and education were found 
significant with perceived support after six months. That means that sex and education predict 
perceived support at six months of dialysis treatment. A trend was found in the prediction of perceived 
support through children. No significant results were found with regard to worrying and self-efficacy. 
That means that worrying and self-efficacy at baseline do not predict changes in perceived support 
over a period of six months during dialysis treatment, ΔR² = .012. 
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Table 11 
Predictors of perceived support after six months dialysis treatment 
Model 
  
t p B SE
a
 βb 
1 Perceived support 
baseline  
.834 .089 .770 9.367 .000* 
Sex  -1.190 .598 -.165 -1.988 .053 
Age .007 .024 .028 .280 .781 
Education  1.256 .521 .214 2.412 .020* 
Children  1.452 .812 .174 1.787 .080 
2 Perceived support 
baseline 
.775 .100 .715 7.772 .000* 
Sex  -1.374 .626 -.191 -2.195 .033* 
Age  .004 .025 .015 .154 .879 
Education  1.441 .544 .246 2.651 .011* 
Children  1.597 .828 .192 1.928 .060 
Worrying  -.045 .036 -.117 -1.262 .213 
Self-efficacy .033 .076 .039 .430 .669 
Notitie. * p < .05
 
a 
SE = standard error
 
b 
β = standardized beta 
 
The last hypothesis, that is that’s higher levels of worry and lower levels of self-efficacy predict a 
deterioration of quality of life over a period of six months during long-term dialysis treatment, is 
adopted for the relation between worrying and emotional functioning. Worrying at baseline predicts a 
decrease in emotional functioning over a period of six months during dialysis treatment. Worrying was 
not found as a predictor of a deterioration of other quality of life measures and self-efficacy was not 
found as a predictor of an improvement of all quality of life measures in renal patients over a period of 
six months during long-term dialysis treatment. For this reason, the hypothesis is rejected. 
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Discussion 
The aim of the current study was to clarify the association between worrying, self-efficacy and quality 
of life in renal patients on dialysis. It was found that patients remained stable in terms of physical 
functioning, emotional functioning and social functioning over a period of half a year during dialysis 
treatment. Associations were found between worrying and fatigue, emotional wellbeing, depression, 
anxiety and perceived support, in which higher levels of worrying were associated with higher levels 
of fatigue, depression and anxiety, and lower levels of emotional wellbeing and perceived support. 
Also associations were found between self-efficacy and symptoms/problems, fatigue, emotional 
wellbeing, depression, anxiety and perceived support, in which higher levels of self-efficacy were 
associated with higher levels of emotional wellbeing and perceived support, and lower levels of 
fatigue, depression, anxiety and symptoms/problems. In addition, worrying predicted a decrease in 
emotional functioning in patients over a period of six months during dialysis treatment. 
 In accordance with the literature, the patients in this sample had deteriorated scores on the 
quality of life factors compared to the general population, in which the general population scored 83.0 
on physical functioning, 84.0 on social functioning (Aaronson et al., 1998), 29.72 on subjective fatigue 
(Beurskens et al., 2000) and 4.75 on depression (Hinz & Brähler, 2011). However, with regard to 
anxiety, the general population scored 4.7 (Hinz & Brähler, 2011), which is higher than the patient 
population. In another population of renal patients, the mean score of symptoms/problems was 71.21, 
which means that that population had less symptoms and problems than the current population 
(Kallich et al., 1997). No information about emotional wellbeing and perceived support of the 
corresponding questionnaires was found.  
 The finding that patients remained stable in the quality of life at baseline and after six months 
during dialysis treatment, led to the adoption of the hypothesis and partly corresponded to previous 
literature (Gabbay et al., 2010; Manns et al., 2003; Merkus, 1997; Mittal et al., 2001). This literature 
describes short-term studies, as well as the current study. A reason for the result that the quality of life 
remained stable can be that the ESRD fluctuates not much in a period of half a year, as well as the 
quality of life. Merkus et al. (1997) found a decrease in physical functioning and Gabbay et al. (2010) 
found an improvement in role-emotional health. Other studies found an improvement (Mazairac et al., 
2010; Santos et al., 2009; Wu et al., 2004) or a decrease in quality of life (Bakewell, Higgins, & 
Edmunds, 2002). The finding that the quality of life improved in other studies may be due to survival 
bias, in which the patients with the worst health died and the patients with the best health remain in the 
participant sample (Santos et al., 2009). Also it could be that patients adjust their standards when they 
are chronically ill, whereby they report a worse quality of life in the first stages of the disease and 
report a improved quality of life at later stages after adjusting their standards (de Ridder, Geenen, 
Kuijer, & van Middendorp, 2008). The period in the current study may be too short to observe this 
difference. In addition, there might be a difference in the results of the changeability of the quality of 
life due to the period when the participants received the questionnaire booklets.  
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For example, in the first months of dialysis, patients can experience the ‘honeymoon stage’, in which 
patients feel physically and mentally better due to physical improvement and trust in the treatment 
(Challinor & Sedgewick, 1998). Contrary to this stage, patients can feel worse immediately after a 
dialysis session, known as ‘post-dialysis hangover’ (Curtin & Mapes, 2001). This hangover can occur 
when fluid is removed in too large amounts or too quickly, where after symptoms like low blood 
pressure, fatigue or headaches occur or worsen. Different conditions, like the honeymoon stage or a 
post-dialysis hangover, can cause differences in participant populations and answers on the questions. 
Because of the different results with regard to the changeability of the quality of life, more research is 
required. The second hypothesis was adopted with regard to the relationship between worrying and 
fatigue, emotional wellbeing, depression, anxiety and perceived support, and self-efficacy and 
symptoms/problems, fatigue, emotional wellbeing, depression, anxiety and perceived support, and 
rejected with regard to the relationship between worrying and physical functioning, 
symptoms/problems and social functioning and self-efficacy and physical functioning and social 
functioning. These results partly corresponded to the literature in which a negative association was 
found between worrying and quality of life in the general population and renal patients (Davey et al., 
1992; Finkelstein et al., 2008; Golden et al., 2011; Kao et al., 2009; Rief et al., 2012), and most studies 
found a positive association between self-efficacy and quality of life in renal patients (Cramm et al., 
2013; Han et al., 2003; Lev & Owen, 1998; Perales-Montilla et al., 2012; Tsay & Healstead, 2002). In 
the current study, no association was found between worrying and physical functioning, 
symptoms/problems, and social functioning and between self-efficacy, physical functioning and social 
functioning, which also were expected due to the mechanisms of the bio-psycho-social model (Engel, 
1977). The lack of correlations with worrying and self-efficacy, may be due to the fact that worrying 
and self-efficacy are more psychological factors, so no correlation was found with physical 
functioning, symptoms/problems and social functioning. Another explanation could be that this patient 
population are not worrying a lot, so not all associations were found. In the current study, a mean 
score of 38.72 was found on the PSWG, but a mean score of 42.2 was found in the general Dutch 
population (van der Heiden, Muris, Bos, van der Molen, & Oostra, 2009). An explanation for the 
finding that the patient population worries less than the general population, may be due to good 
education about the disease, acceptance of the disease, and enjoyment of the most important things in 
life (de Ridder, Geenen, Kuijer, & van Middendorp, 2008). The last hypothesis was adopted regarding 
the association between worrying and emotional functioning and rejected in terms of the other quality 
of life measures in relation to worrying and self-efficacy. These results partly corresponded to the 
literature in which worrying (Augusto et al., 2011) and self-efficacy (Cramm et al., 2013; Tsay & 
Healstead, 2002) were found as predictors of quality of life.  
 The current study has several limitations. The participant population consisted of 126 patients 
at baseline and 65 at follow-up. Unfortunately, almost half of the participants is missing at follow-up, 
for unknown reasons.  
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However, the analysis in which the means of the baseline measures of the participants who filled in 
only the first questionnaires and the participants who filled in both questionnaires were compared 
showed no differences in quality of life. Furthermore, a lot of questionnaires were questioned, but not 
all questionnaires were focused on renal patients. It would be better that all patient groups have their 
own questionnaires, to focus on specific aspects or symptoms in which specific patients experience 
difficulties. 
 However, the study consists of several strong points. The study has a broad focus on a lot of 
aspects of quality of life and other measures, questioned by lots of questionnaires. Furthermore, the 
study consists of participants from different hospitals and medical centers, whereby a large, 
heterogeneous group was developed. Another strong point, is that the study is prospective, so a 
possible change in quality of life could be measured. Last, the population of renal patients is an 
important group for study because of the severity of the disease. More research can provide more 
information and treatments for renal patients and the quality of life. 
 The current study was done to clarify the association between worrying, self-efficacy and 
quality of life in renal patients on dialysis. Different associations and predictions, with regard to the 
quality of life, were found. With specific treatments for these findings, patients can be treated more 
focused on these aspects. For example, previous research focused on dialysis treatment with 
interventions including exercise, hormonal therapy and carnitine treatment (Mazairac et al., 2010). 
Treatment like this can lead to an increase in the quality of life in renal patients. 
 Further research can be focused on other changeable predictors for the quality of life. If these 
factors become more clear, treatments can be more focused on these factors, which can cause further 
increase of the quality of life.  
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